Clinical Trial

Diagnostic Application of AI-ROSE in Severe Pneumonia

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
AI-ROSE is an innovative immunofluorescence staining combined with artificial intelligence image analysis technology that uses a fully automated fluorescence microscope to image pathogens in real time. AI algorithms automatically identify pathogen types (such as bacteria, fungi, etc.) and cellular backgrounds, quickly interpret results, and automatically issue color graphic reports for clinical doctors to take earlier and more accurate targeted treatment for critically ill patients. This study used bronchoalveolar lavage fluid as a biological sample and compared it with traditional examination methods to analyze the diagnostic accuracy and clinical practicality of AI-ROSE in patients with severe pneumonia.
Trial Details
NCT Number NCT07113951
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Severe Pneumonia, Bacterial Infections
Enrollment 100 participants
Start Date 2025-08-31
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-11